(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, secretion, ...
Jan 30, 2013
0
0
The American College of Physicians (ACP) today urged Congress to pass legislation that will "create a permanent solution to the endless cycle of Medicare physician payment cuts." Three-page letters were sent to U.S. House ...
Dec 17, 2012
0
0
Researchers at UT Southwestern Medical Center have taken another step toward better understanding the metabolic functions of obesity and its connection to type 2 diabetes.
Dec 17, 2012
0
0
In a commentary to be published in the Dec. 12 issue of The Journal of the American Medical Association, two Johns Hopkins faculty members predict an ever-diminishing role for government and drug company funding of basic ...
Nov 26, 2012
0
0
(HealthDay) -- The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action, according to a study published online April 9 in Diabetes.
Apr 14, 2012
0
0
